Search

everythinglearnresearchcommunity

for

Search:↓

Low estrogen compared to androgen may cause female hair loss.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Estrogen deficiency, like after menopause or certain surgeries, leads to faster skin aging and health issues.

Estrogen receptors may not affect mouse hair growth as previously thought, and oxybenzone in sunscreen is stable in sunlight.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Hormones during puberty increase certain receptors in the brain, and this change is influenced by estrogen levels.

Men born very underweight had higher estrogen levels but normal reproduction compared to normal birth weight men.

Transgender women on estrogen therapy can develop melasma and need proper skin care.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

The paper suggests that a decrease in estrogen receptor activity may cause sexual dysfunction syndromes and proposes hormonal treatments.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Higher androgen receptor levels in bald areas may cause hair loss, while estrogen receptors have less impact.

Treatments for hair loss include estrogen therapy and special shampoos.

Genetics, low estrogen, and low iron levels contribute to female hair loss, with specific scalp signs indicating severity.

Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Human sebaceous glands can grow normally for a week without certain growth factors, and adding estrogen reduces their oil production without affecting cell growth.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.